The FDA has approved Otsuka Pharmaceutical’s SIMTRIYO (centanafadine) for the treatment of attention...
Adults with treatment-resistant depression (TRD) experienced rapid and significant improvement in sy...
Small nerve fibers in subjects with fibromyalgia syndrome are impaired, Nurcan Uceyler, M.D., of the...
ppart/Shutterstock On Tuesday, the Food and Drug Administration (FDA) released two drug-safety commu...
